Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-28A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-09-28A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-09-17A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
-
CLINICAL_TRIALS study results posted · 2026-09-10A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study results posted · 2026-09-10A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-08-12Utility of Intestinal Ultrasound as a Diagnostic Tool for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis: A Prospective Pilot Study
-
CLINICAL_TRIALS study results posted · 2026-06-23Assessing Effectiveness and Implementation of a Perioperative Enhanced Recovery Protocol for Children Undergoing Gastrointestinal Surgery
-
CLINICAL_TRIALS study results posted · 2026-06-23A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE)
-
CLINICAL_TRIALS study results posted · 2026-06-23A 54-Week, Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (Expedition Lead-in)
-
CLINICAL_TRIALS study results posted · 2026-06-23Randomized, Double-blind, Phase 2 Study to Evaluate the Efficacy and the Safety of OSE-127 Versus Placebo in Subjects With Moderate to Severe Active Ulcerative Colitis Who Have Failed or Are Intolerant to Previous Treatment(s)
-
CLINICAL_TRIALS study results posted · 2026-06-15A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Phase 2 Induction Study With Long-Term Extension to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants w/ Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study results posted · 2026-06-08Direct Measurement of Gastrointestinal Permeability Change in Response to Aquamin®
-
CLINICAL_TRIALS study record update · 2026-06-03A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-06-03Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies
-
CLINICAL_TRIALS study record update · 2026-06-02OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
-
CLINICAL_TRIALS study record update · 2026-04-27IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
-
CLINICAL_TRIALS study record update · 2026-04-27A Follow-up Phase II Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 Given at 25 mg Once Daily in Subjects With Moderate to Severe Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-27Describing Prescription Patterns in an Ulcerative Colitis Population and Generating an Updated Ulcerative Colitis Treatment Paradigm
-
CLINICAL_TRIALS study record update · 2026-04-27Therapeutic Effect of New Biologics in Crohn's Disease
-
CLINICAL_TRIALS study record update · 2026-04-27Adjunctive Treatment With Vitamin D3 in Patients With Active IBD (ACTIVATED): A Randomized, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-27An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-24Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
-
CLINICAL_TRIALS study record update · 2026-04-24Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation
-
CLINICAL_TRIALS study record update · 2026-04-24Predictors of Response After Induction Therapy With TNF-alpha Inhibitor in Inflammatory Bowel Disease, Comparison to Normal